GlassScriptPhysician profile
Marcus J Mittelsteadt
NPI 1215347117
$9,937.34
in general payments reported to CMS, 2019-2025
10 companies · $696 in 2025
The $696 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $3,980 · 2021: $2,478 · 2022: $1,098 · 2023: $1,014 · 2024: $337 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,047.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,229.60 | 2019-2025 | Allofiber, Variax, Ortholoc 3di |
| Arthrex, INC. | $1,837.12 | 2020 | |
| Gemini Medical LLC | $1,619.00 | 2020 | |
| Smith+Nephew, INC. | $444.95 | 2020-2025 | Q-Fix, Bone Anchors With Arthroscopic Delivery System, Healicoil |
| Paragon 28, INC. | $413.39 | 2020-2025 | Apex 3d |
| Wright Medical Technology, INC. | $208.45 | 2020 | |
| Orthofix Medical, INC. | $87.49 | 2021-2025 | Physio-Stim |
| Treace Medical Concepts, INC. | $45.39 | 2023-2024 | |
| Depuy Synthes Sales INC. | $36.54 | 2019 | |
| Integra Lifesciences Corporation | $15.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Mittelsteadt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.